Counselors in Longboat Key, FL Accepting Medicare
2 Counselors found. Showing 1 - 2
 Mrs. Kelly Ann Dowiak, LPC, LMHC, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 6350 Gulf Of Mexico Dr Ste 103a, Longboat Key, FL 34228 Phone: 724-591-2440 |
Ms. Renee Karas Crames, MS LCSW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 535 Sanctuary Drive A 402, Longboat Key, FL 34228 Phone: 941-383-5056 |
News Archive
IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
Cisplatin anti-cancer drug binds pervasively to RNA
An anti-cancer drug used extensively in chemotherapy binds pervasively to RNA - up to 20-fold more than it does to DNA, a surprise finding that suggests new targeting approaches might be useful, according to University of Oregon researchers.
Nordson Corporation acquires Fluortek, Inc., expanding medical tubing offerings for complex medical devices
Nordson Corporation has acquired Fluortek, Inc., an Easton, Pennsylvania based precision plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry.
Momenta receives patent for methods to evaluate enoxaparin
Momenta Pharmaceuticals, Inc. a biotechnology company specializing in the characterization and engineering of complex drugs, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,816,144, entitled "Evaluating Mixtures of Low Molecular Weight Heparins By Chain Profiles or Chain Mapping". The patent includes claims to methods of analyzing and processing enoxaparin by analyzing chain sequence information.
Women's risk factors for heart disease
Heart disease is often thought of as a health problem for men, but more and more women die of heart disease each year than men, and from any other disease including breast cancer.
› Verified 8 days ago